1. Home
  2. IPO
  • Curis Lifesciences IPO
Curis Lifesciences Ltd

Curis Lifesciences IPO

  • Status: Closed
  • RHP:
  • ₹ 240,000 / 2000 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    14 Nov 2025

  • Listing Price

    ₹ 146.10

  • Listing Change

    14.14%

  • Last Traded Price

    ₹ 115.00

Curis Lifesciences IPO Details

  • Open Date

    07 Nov 2025

  • Close Date

    11 Nov 2025

  • Listing Date

    14 Nov 2025

  • IPO Price Range

    ₹ 120 to ₹128

  • IPO Size

    ₹ 27.52 Cr

  • Listing Exchange

    NSE SME

Open Free Demat Account

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

Curis Lifesciences IPO Timeline

Curis Lifesciences IPO Subscription Status

Last Updated: 11 November 2025 6:06 PM by 5paisa

Curis Lifesciences Limited, launching a ₹27.52 Cr IPO, is a pharmaceutical company engaged in developing, manufacturing, and distributing a wide range of products. Operating from its state-of-the-art facility in Sanand, Gujarat, the company ensures strict quality and safety standards. It produces tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Curis serves over 100 corporate clients globally through loan licences and contract manufacturing, with branded operations in Yemen and Kenya. 

Established in: 2010 

Managing Director: Mr. Dharmesh Dasharathbhai Patel 

Peers: 

Sotac Pharmaceuticals Limited 
Lincoln Pharmaceuticals Limited 

Curis Lifesciences Objectives

1. The company will upgrade existing manufacturing facilities (₹2.44 crores). 
2. It plans to construct a new storage facility (₹3.62 crores). 
3. Funds will be used to repay secured loans (₹1.86 crores). 
4. The company aims to register products internationally (₹2.69 crores). 
5. It will fund working capital requirements (₹11.25 crores). 
6. Remaining funds will support general corporate purposes. 

Curis Lifesciences IPO Size

Types Size
Total IPO Size ₹27.52 Cr
Offer For Sale -
Fresh Issue ₹27.52 Cr

Curis Lifesciences IPO Lot Size

Application Lots Shares Amount (₹)
Retail (Min) 2 2,000 2,40,000
Retail (Max) 2 2,000 2,56,000
S-HNI (Min) 3 3,000 3,60,000
S-HNI (Max) 7 7,000 8,96,000
B-HNI (Min) 8 8,000 9,60,000

Curis Lifesciences IPO Reservation

Investors Category Subscription (times) Shares Offered* Shares bid for Total Amount (Cr.)*
QIB (Ex Anchor) 96.17     4,09,000     3,93,35,000     503.49    
Non-Institutional Buyers 115.46     3,08,000     3,55,63,000     455.21    
bNII (bids above ₹10L) 142.74     2,06,000     2,94,04,000     376.37    
sNII (bids below ₹10L) 60.38     1,02,000     61,59,000     78.84    
Retail Investors 44.28     7,16,000     3,17,06,000     405.84    
Total** 74.39     14,33,000     10,66,04,000    1,364.53    

 

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Curis Lifesciences IPO Anchor Allocation

Particulars Details
Anchor Bid Date 6 November 2025
Shares Offered 6,10,000
Anchor Portion Size (In ₹ Cr.) 7.81
Anchor Lock-in Period End Date for 50% Shares (30 Days) 12 December 2025
Anchor Lock-in Period End Date for Remaining Shares (90 Days) 10 February 2026

Profit and Loss

Balance Sheet

Particulars (In ₹ Crores) FY23 FY24 FY25
Revenue 35.45 35.56 49.13
EBITDA 3.27 8.39 9.54
Profit After Tax (PAT) 1.88 4.87 6.11
Particulars (In ₹ Crores) FY23 FY24 FY25
Total Assets 29.75 33.88 42.53
Share Capital 0.50 0.50 5.93
Total Liabilities 12.14 9.81 9.46
Particulars (In ₹ Crores) FY23 FY24 FY25
Net Cash Generated From / (used in) Operating Activities 3.35 0.28 -1.76
Net Cash Generated From / (used in) Investing Activities -0.56 -0.06 -0.02
Net Cash Generated From / (used in) Financing Activities -2.76 0.05 1.67
Net Increase / (Decrease) In Cash And Cash Equivalents 0.04 0.27 -0.11


Strengths

1. State-of-the-art manufacturing facility in Gujarat. 
2. Diverse product portfolio across multiple formulations. 
3. Strong client network in domestic and global markets. 
4. Strict adherence to quality and safety standards. 

Weaknesses

1. Limited brand presence in highly competitive markets. 
2. Dependence on loan licence and contract manufacturing. 
3. Regulatory approvals can delay international market entry. 
4. High capital investment required for facility upgrades. 

Opportunities

1. Expanding presence in emerging global pharmaceutical markets. 
2. Increasing demand for affordable, quality healthcare products. 
3. Product registration in new countries boosts reach. 
4. Technological upgrades can enhance production efficiency. 

Threats

1. Intense competition from domestic and global pharma firms. 
2. Frequent changes in international regulatory requirements. 
3. Currency fluctuations affecting export profitability. 
4. Rising raw material costs impacting profit margins. 

1. Strong presence in global pharmaceutical manufacturing markets. 
2. Advanced facility ensuring quality and regulatory compliance. 
3. Expansion plans to increase production and efficiency. 
4. Rising demand for affordable healthcare products worldwide. 

Curis Lifesciences Limited operates in the growing pharmaceutical sector, focusing on manufacturing high-quality formulations for global and domestic markets. With a modern facility in Gujarat and over 100 corporate clients, the company maintains strong technical expertise and regulatory compliance. The IPO aims to fund capacity.

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Curis Lifesciences IPO opens from November 7, 2025 to November 11, 2025.

The size of Curis Lifesciences IPO is ₹27.52 Cr.

The price band of Curis Lifesciences IPO is fixed at ₹120 to ₹128 per share.

To apply for Curis Lifesciences IPO, follow the steps given below: 

●    Login to your 5paisa demat account and select the issue in the current IPO section     

●    Enter the number of lots and the price at which you wish to apply for the Curis Lifesciences IPO.     

●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.     

You will receive a mandate notification to block funds in your UPI app. 

The minimum lot size of Curis Lifesciences IPO is of 2,000 shares and the investment required is ₹2,40,000.

The share allotment date of Curis Lifesciences IPO is November 12, 2025

The Curis Lifesciences IPO will likely be listed on November 14, 2025.

Finaax Capital Advisors Private Limited is the book running lead managers for Curis Lifesciences IPO.

Curis Lifesciences IPO plans to utilise the raised capital from the IPO for: 

  • The company will upgrade existing manufacturing facilities (₹2.44 crores). 
  • It plans to construct a new storage facility (₹3.62 crores). 
  • Funds will be used to repay secured loans (₹1.86 crores). 
  • The company aims to register products internationally (₹2.69 crores). 
  • It will fund working capital requirements (₹11.25 crores). 
  • Remaining funds will support general corporate purposes.